Canadian advanced materials company HPQ Silicon Inc. (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08) recently announced that its French technology partner NOVACIUM SAS has officially started industrial production of lithium-ion battery cells using its third-generation (GEN3) silicon-based anode material.
Previously, the company published reports on July 30, 2024 and March 19, 2025, respectively, highlighting the excellent test results of 18650-sized cells manufactured with GEN3 anode materials. These batteries have attracted the attention of major players in the energy, mobility, consumer electronics, telecommunications and defense sectors by demonstrating high capacity and long cycle life.
With a capacity of up to 4,000 mAh and supporting 1,000 charging cycles, the new cells are ideal for demanding applications. To meet the growing demand, Novacium is accelerating the industrialization of its battery technology.
“Our goal is to deliver the first commercial cells and establish partnerships by the end of the third quarter of 2025,” said a Novacium spokesperson.
To achieve this goal, Novacium worked with a large industrial manufacturer who quickly adapted its production line to incorporate the GEN3 anode. This rapid integration demonstrated the compatibility of the GEN3 material with existing battery manufacturing systems.
Initial production has produced two cylindrical cell sizes: 18650 (4,000 mAh) and 21700 (6,000 mAh). The performance metrics of these cells make them among the highest performing cells on the market and are consistent with early lab-scale test results.
Novacium’s ability to work with a factory that produces tens of millions of cells per year has enabled it to quickly scale up and reach commercial production in the short term.
Dr. Kraiem of Novacium said of the development results: “The performance of our new commercial battery proves the strength of our technology and flexible industrial strategy. We have completed laboratory testing, these are real products, ready for market evaluation.”
This production is also a key step for HPQ to generate revenue, attract new investment and support its North American battery production plan. As the exclusive licensee of GEN3 technology in North America, HPQ is preparing to start local production in Canada to meet the growing demand for batteries.
Bernard Tourillon, CEO of HPQ Silicon Inc. and Novacium SAS, said: “This launch proves that our collaboration with Novacium is delivering tangible, market-ready results. We are not just responding to trends, we are leading them.”
Tourillon added: “With our exclusive rights in North America and Novacium’s rapid development, HPQ is well positioned to benefit from technology transfer, meet market demand and generate revenue by the end of the year. This is a key step in the monetization of our technology portfolio.”
The launch marks a major shift from research to commercialization for both companies, making them agile players in the global electrification and advanced energy storage sectors.
